Search Results 101-110 of 17363 for hba1c

1. A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia - Mayo Clinic

   - Hemoglobin A1c (HbA1c) ≥ 9.5% at Screening. - Alanine aminotransferase or aspartate aminotransferase > 3.0 × upper limit of normal. - Total bilirubin ...

2. A Study Comparing the Effectiveness and Safety of the Morning Injection of Toujeo versus Lantus in Patients with Type 1 Diabetes Mellitus - Mayo Clinic

   Glycated hemoglobin (HbA1c) <7.0% or >9.0% via central lab test at visit 1; Experienced none or only 1 episode of documented symptomatic and/or severe ...

3. INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) - Mayo Clinic

   HbA1c ≥ 8%;; NOTE: HbA1c is not a required screening lab; however, if HbA1C is performed at screening, result must be < 8%. NOTE: If patient's HbA1c is ≥ 8 ...

4. A Study to Evaluate the Safety and Effectiveness of Obeticholic Acid Treatment on People with Non-Alcoholic Steatohepatitis with Fibrosis - Mayo Clinic

   HbA1c > 9.5% within 60 days before Day 1. Evidence of other forms of known chronic liver disease including: Positive test result at Screening for hepatitis ...

5. A Study of the Impact of Decision Aids to Enhance Shared Decision Making for Diabetes - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

6. Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus - Mayo Clinic

   Subjects with HbA1c > 8%; Females who are pregnant or breastfeeding; Concomitant use of appetite suppressants, orlistat, phentermine-topiramate ER or ...

7. A Study of the Clinical Experience and Acceptance of the Artificial Pancreas

   HbA1c level <10.5% at screening; For females, not currently known to be pregnant. If female and sexually active, must agree to use a form of contraception to ...

8. A Study to Evaluate How Semaglutide Works Compared to Placebo in People with Type 2 Diabetes and Chronic Kidney Disease - Mayo Clinic

   Male or female, age above or equal to 18 years at the time of signing informed consent. · Diagnosed with type 2 diabetes mellitus. · HbA1c less than or equal to ...

9. Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen - Mayo Clinic

   Poorly controlled diabetes mellitus defined as having a HbA1c ≥8.5% (ie, ≥69.5 mmol/mol) or estimated HbA1c based on fructosamine if HbA1c is not evaluable ( ...

10. Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis - Mayo Clinic

    Uncontrolled diabetes mellitus (HbA1c >9%); Diabetes medications should be stable within 3 months of screening except for medications titrated to blood ...